These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2959409)

  • 21. Effect of short-term administration of N-(4-hydroxyphenyl)-all-trans-retinamide on chemically induced mammary tumors.
    Silverman J; Katayama S; Radok P; Levenstein MJ; Weisburger JH
    Nutr Cancer; 1983; 4(3):186-91. PubMed ID: 6221232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal retinal function associated with fenretinide, a synthetic retinoid.
    Kaiser-Kupfer MI; Peck GL; Caruso RC; Jaffe MJ; DiGiovanna JJ; Gross EG
    Arch Ophthalmol; 1986 Jan; 104(1):69-70. PubMed ID: 2935125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of mammary tumorigenesis in nulliparous C3H mice by chronic feeding of the synthetic retinoid, N-(4-hydroxyphenyl)-retinamide.
    Welsch CW; DeHoog JV; Moon RC
    Carcinogenesis; 1983 Sep; 4(9):1185-7. PubMed ID: 6224605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution and metabolism of the retinoid, N-(4-methoxyphenyl)-all-trans-retinamide, the major metabolite of N-(4-hydroxyphenyl)-all-trans-retinamide, in female mice.
    Hultin TA; Filla MS; McCormick DL
    Drug Metab Dispos; 1990; 18(2):175-9. PubMed ID: 1971569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipromotional activity of dietary N-(4-hydroxyphenyl)retinamide in two-stage skin tumorigenesis in CD-1 and SENCAR mice.
    McCormick DL; Moon RC
    Cancer Lett; 1986 May; 31(2):133-8. PubMed ID: 2938725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biotransformation and biological activity of N-(4-hydroxyphenyl)retinamide derivatives in rodents.
    Swanson BN; Newton DL; Roller PP; Sporn MB
    J Pharmacol Exp Ther; 1981 Dec; 219(3):632-7. PubMed ID: 6170750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acitretin treatment of severe psoriasis.
    Török L; Kádár L; Geiger JM
    Acta Derm Venereol Suppl (Stockh); 1989; 146():104-6. PubMed ID: 2532840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of fenretinide in the mammary gland of breast cancer patients.
    Mehta RG; Moon RC; Hawthorne M; Formelli F; Costa A
    Eur J Cancer; 1991; 27(2):138-41. PubMed ID: 1827276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-(4-hydroxyphenyl)retinamide (Fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins.
    Takahashi N; Sausville EA; Breitman TR
    Clin Cancer Res; 1995 Jun; 1(6):637-42. PubMed ID: 9816026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of fenretinide and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics.
    Cho HE; Min HK
    J Pharm Biomed Anal; 2017 Jan; 132():117-124. PubMed ID: 27701038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of acyl coenzyme A:retinol acyltransferase in rat liver and mammary tumor tissue by retinyl acetate and its competitive inhibition by N-(4-hydroxyphenyl) retinamide.
    Ball MD; Furr HC; Olson JA
    Biochem Biophys Res Commun; 1985 Apr; 128(1):7-11. PubMed ID: 3157381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 12-month treatment of severe psoriasis with acitretin: results of a Canadian open multicenter study.
    Murray HE; Anhalt AW; Lessard R; Schacter RK; Ross JB; Stewart WD; Geiger JM
    J Am Acad Dermatol; 1991 Apr; 24(4):598-602. PubMed ID: 1827800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secretion of vitamin A and retinol-binding protein into plasma is depressed in rats by N-(4-hydroxyphenyl)retinamide (fenretinide).
    Smith JE; Lawless DC; Green MH; Moon RC
    J Nutr; 1992 Oct; 122(10):1999-2009. PubMed ID: 1388202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrolysis of 4-HPR to atRA occurs in vivo but is not required for retinamide-induced apoptosis.
    Chapman JS; Weiss KL; Curley RW; Highland MA; Clagett-Dame M
    Arch Biochem Biophys; 2003 Nov; 419(2):234-43. PubMed ID: 14592467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Eruption of fleshy nodules during tretinoin treatment of acne].
    Dal Tio R
    Dermatologica; 1985; 171(5):376-7. PubMed ID: 2934282
    [No Abstract]   [Full Text] [Related]  

  • 36. [Oral treatment of severe forms of psoriasis by an analog of vitamin A acid].
    Ott F; Bollag W
    Ann Dermatol Syphiligr (Paris); 1976; 103(5-6):619-20. PubMed ID: 797300
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk: benefit ratio in the treatment of psoriasis with systemic retinoids.
    Halioua B; Saurat JH
    Br J Dermatol; 1990 Jun; 122 Suppl 36():135-50. PubMed ID: 2142437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cutaneous aspergillosis complicating tumor necrosis factor-α blockade therapy in a patient with psoriasis.
    Osório F; Magina S; Azevedo F
    Actas Dermosifiliogr; 2012 Dec; 103(10):939-41. PubMed ID: 23182382
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of 13-cis-retinoic acid and 4-hydroxyphenyl-all-trans-retinamide on human tumor colony formation in soft agar.
    Meyskens FL; Alberts DS; Salmon SE
    Int J Cancer; 1983 Sep; 32(3):295-9. PubMed ID: 6224747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer.
    Clifford JL; Sabichi AL; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Lippman SM
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):391-5. PubMed ID: 11319181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.